28Jan 2024
Predicting Treatment Response in HER2-Positive Breast Cancer: A Nomogram Approach

Predicting Treatment Response in HER2-Positive Breast Cancer: A Nomogram Approach

The retrospective study of 353 HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy revealed that ER status, PR status, HER2 status, Ki-67 index, and chemotherapy regimens independently influenced pathological complete response (pCR) rates. A nomogram predicting pCR probability demonstrated an area under the curve of 0.73. Notably, ER-negative, PR-negative, HER2 3+, and high Ki-67 index patients were more likely to achieve pCR. The study suggests considering THP as an alternative to AC-THP or TCbHP in specific HER2-positive patients.

  • #oncology

Like

Save

Share